Daniel Nam

Daniel Nam supports clients with research and analysis that span a variety of healthcare sectors and stakeholders.

He applies his background as a pharmacist, attorney, and healthcare policy expert to a broad range of client projects, especially those pertaining to pharmacy practice and Medicare Part D.

Prior to joining Avalere, Daniel held a variety of positions. Most recently, as an executive director of pharmacy with America’s Health Insurance Plans, he provided policy, regulatory, and legislative analyses on pharmacy, pharmaceutical, Medicare Part D, and other payment-related issues for health plans. Daniel also has experience as a practicing pharmacist in community pharmacy and clinical hospital settings, as a small business owner, and as a congressional healthcare staffer and fellow.

Authored Content

Implementation of a preferred specialty tier could have various impacts on Part D plans’ formulary and benefit designs and could affect manufacturer contracting strategies.